Statistically significant lower risk is seen for recovery and viral clearance. 2 studies from 2 independent teams (both from the same country) show statistically significant improvements.
Meta analysis using the most serious outcome reported shows 11% [-1‑21%] lower risk, without reaching statistical significance. Results are better for Randomized Controlled Trials.
Currently there is limited data, with only 1 control event for the most serious outcome in trials to date. Studies to date are from only 2 different groups.
No treatment or intervention is 100% effective. All practical, effective, and safe means should be used based on risk/benefit analysis. Multiple treatments are typically used in combination, and other treatments are significantly more effective.
All data to reproduce this paper and sources are in the appendix. Zheng present another meta analysis for deuremidevir, showing significant improvement for viral clearance.
Covid Analysis et al., May 2024, preprint, 1 author.